SkinPen Milestone Highlights Growth in Microneedling Demand

Revance announced that it has distributed more than 1 million SkinPen treatment kits nationwide since January 2025, marking a milestone for the company’s microneedling portfolio. The achievement comes approximately 1 year after the launch of SkinPen Precision Elite, the latest iteration of the device.

SkinPen is positioned as a leading microneedling platform in the United States, with the Precision Elite device designed to enhance consistency and provider control through updated balance and ergonomics. According to the company, the system builds on earlier versions of SkinPen, which are used for mechanical microneedling procedures intended to improve skin appearance with minimal downtime.

“Reaching 1 million SkinPen treatment kits sold since January 2025 is a powerful proof point—not only for SkinPen, but for the rapid growth of microneedling as an in-demand aesthetic treatment,” said Nadeem Moiz, Chief Executive Officer of Revance. “This momentum reflects our continued commitment to advancing the category through innovation, education, and clinically supported outcomes.”

To coincide with the milestone, Revance launched the “$100 Reasons to Love SkinPen” rebate program, offering patients $100 off a series of 3 or more treatments between February 1 and June 30, 2026. The company stated that the initiative is intended to support patient access and continued utilization.